Form 4 for XTNT Xtant Medical Holdings, Inc.
Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-15 · accession 0001235802-21-000102 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-17 | 2021-08-15 | XTNT | JENSEN GREG | VP, CFO, Fin | A - Grant | $0.00 | +156.2K | 285.3K | +121% | $0 |
| D | 2021-08-17 | 2021-08-15 | XTNT | JENSEN GREG | VP, CFO, Fin | A - Grant | $0.00 | +192.3K | 192.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.000001 par value | 2021-08-15 | A | A | 156,250 | $0.00 | 285,331 | D | — | — | (F1) These shares will vest and be issued with respect to 39,062 shares on each of August 15, 2022, August 15, 2023 and August 15, 2024 and with respect to 39,064 shares on August 15, 2025 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. (F2) Includes 244,587 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. |
| 2 | Derivative | Stock Option (right to buy) | 2021-08-15 | A | A | 192,308 | $0.00 | 192,308 | D | $1.27 · — to 2031-08-15 | 192,308 Common Stock | (F3) This option vests with respect to 48,077 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc. |